Advancement of nanomedicines in chronic inflammatory disorders
Chronic diseases, as stated by the WHO, are a threat to human health which kill 3 out of
every 5 people worldwide. Therapeutics for such illnesses can be developed using …
every 5 people worldwide. Therapeutics for such illnesses can be developed using …
A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis
Tuberculosis (TB) has been the most life-threatening contagious disease caused by
pathogenic mycobacterium tuberculosis. The World Health Organization (WHO) report, 2020 …
pathogenic mycobacterium tuberculosis. The World Health Organization (WHO) report, 2020 …
Right or left: the role of nanoparticles in pulmonary diseases
Due to the rapid development of the nanotechnology industry in the last decade,
nanoparticles (NPs) are omnipresent in our everyday life today. Many nanomaterials have …
nanoparticles (NPs) are omnipresent in our everyday life today. Many nanomaterials have …
Macrophage-targeted nanomedicines for ARDS/ALI: Promise and potential
R Vichare, JM Janjic - Inflammation, 2022 - Springer
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by
progressive lung impairment typically triggered by inflammatory processes. The mortality toll …
progressive lung impairment typically triggered by inflammatory processes. The mortality toll …
Nanomedicine for respiratory diseases
Nanotechnology provides new materials in the nanometer range with many potential
applications in clinical medicine and research. Due to their unique size-dependent …
applications in clinical medicine and research. Due to their unique size-dependent …
Nanotechnology in respiratory medicine
Like two sides of the same coin, nanotechnology can be both boon and bane for respiratory
medicine. Nanomaterials open new ways in diagnostics and treatment of lung diseases …
medicine. Nanomaterials open new ways in diagnostics and treatment of lung diseases …
The nanosystems involved in treating lung cancer
Even though there are various types of cancer, this pathology as a whole is considered the
principal cause of death worldwide. Lung cancer is known as a heterogeneous condition …
principal cause of death worldwide. Lung cancer is known as a heterogeneous condition …
Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders
Inflammatory lung disorders have become one of the fastest growing global healthcare
concerns, with more than 500 million annual cases of disorders such as chronic obstructive …
concerns, with more than 500 million annual cases of disorders such as chronic obstructive …
Nanotechnology solutions for mucosal immunization
S Chadwick, C Kriegel, M Amiji - Advanced drug delivery reviews, 2010 - Elsevier
The current prevalence of infectious diseases in many developing regions of the world is a
serious burden, impacting both the general health as well as economic growth of these …
serious burden, impacting both the general health as well as economic growth of these …